Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Romlusevimab (BRII-198) is a human IgG1 monoclonal antibody that neutralizes the SARS-CoV-2 spike protein, effectively targeting the virus responsible for severe acute respiratory syndrome [1] [2].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry |
Description | Romlusevimab (BRII-198) is a human IgG1 monoclonal antibody that neutralizes the SARS-CoV-2 spike protein, effectively targeting the virus responsible for severe acute respiratory syndrome [1] [2]. |
Molecular Weight | N/A |
CAS No. | 2509447-08-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Romlusevimab 2509447-08-7 inhibitor inhibit